Award recordCONTRACT

PFIZER INC

PIID VA24714F0188· VHA· 247-NETWORK CONTRACT OFFICE 7 (36C247)· 6505 · DRUGS AND BIOLOGICALS· FY2014· $68,312 net obligations· UEI MHBQULRMEEJ5· NY

Description

DE-OBLIGATION OF REMAINING FUNDS FOR SOMAVERT 15MG VIAL0

Base award description: SOMAVERT 15MG VIAL0

First action · last action
2013-10-04 · 2017-04-10
Transactions
3
First transaction's obligation
$73,447
Base + all options value (sum of deltas)
$160,776
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
3
SDVOSB flag on record
No
Parent IDV
VA797BP0412
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$80,388$0Base award · 2013-10-04 · this action $73,447 · running total $73,447Modification P00001 · 2014-02-11 · this action $6,941 · running total $80,388Modification P00002 · 2017-04-10 · this action -$12,077 · running total $68,312
  • Base2013-10-04+$73,447= $73,447
  • Mod P000012014-02-11+$6,941= $80,388
  • Mod P000022017-04-10-$12,077= $68,312
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2013-10-04+$73,447$73,447SOMAVERT 15MG VIAL0
Mod P00001· FUNDING ONLY ACTION2014-02-11+$6,941$80,388SOMAVERT 15MG VIAL0
Mod P00002· CLOSE OUT2017-04-10−$12,077$68,312DE-OBLIGATION OF REMAINING FUNDS FOR SOMAVERT 15MG VIAL0

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI MHBQULRMEEJ5)

AwardOffice · PSC / listingNet obligationsFY
36E79725D0032NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025
36E79725D0030NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025
36C77024P0393NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$243,101FY2024
36F79724D0130NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
36C25024F0047250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$215,205FY2024
36E79723A0023NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2023

Other recipients under 6505 from 247-NETWORK CONTRACT OFFICE 7 (36C247) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24726P0690SINA DRUG LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$188,463FY2026
36C24726N0211BOSTON SCIENTIFIC CORP247-NETWORK CONTRACT OFFICE 7 (36C247)$248,982FY2026
36C24726F0100AMICUS THERAPEUTICS US, LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$228,396FY2026
36C24726F0053EXELAN PHARMACEUTICALS INC247-NETWORK CONTRACT OFFICE 7 (36C247)$4,765,853FY2026
36C24726F0043AMICUS THERAPEUTICS US, LLC247-NETWORK CONTRACT OFFICE 7 (36C247)$109,456FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24714F0188_3600_VA797BP0412_3600 · retrieved 2026-09-26.